Journey Medical
DERM
Journey Medical (DERM) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.01
- EPS estimate
- −$0.02
- EPS surprise
- +55.56%
- Revenue surprise
- +0.82%
- Revenue
- $18.5M
- Revenue estimate
- $18.4M
- Reported
- Aug 12, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | −$0.02 | −$0.01 | +55.56% | $18.5M | SEC |
| Q1 2026 | May 13, 2026 | −$0.09 | −$0.08 | +8.57% | $16.0M | SEC |
| Q4 2025 | Mar 25, 2026 | −$0.04 | −$0.04 | +0.00% | $16.1M | SEC |
| Q3 2025 | Nov 12, 2025 | −$0.05 | −$0.09 | −89.47% | $17.6M | SEC |
| Q2 2025 | Aug 12, 2025 | −$0.11 | −$0.16 | −52.38% | $15.0M | SEC |
| Q1 2025 | May 14, 2025 | −$0.24 | −$0.18 | +24.21% | $13.1M | SEC |
| Q4 2024 | Mar 26, 2025 | −$0.20 | $0.10 | +150.63% | $13.6M | SEC |
| Q3 2024 | Nov 12, 2024 | −$0.17 | −$0.12 | +29.41% | $14.6M | SEC |
| Q2 2024 | Aug 12, 2024 | −$0.14 | −$0.17 | −18.63% | $14.9M | SEC |
| Q1 2024 | May 13, 2024 | −$0.24 | −$0.53 | −125.53% | $13.0M | SEC |
| Q4 2023 | Mar 21, 2024 | −$0.09 | −$0.59 | −594.12% | $15.3M | SEC |
| Q3 2023 | Nov 7, 2023 | −$0.16 | $0.99 | +738.71% | $34.5M | SEC |
| Q2 2023 | Aug 8, 2023 | −$0.34 | −$0.04 | +88.06% | $17.2M | SEC |
| Q1 2023 | May 22, 2023 | −$0.45 | −$0.57 | −27.60% | $12.2M | SEC |
| Q4 2022 | Mar 29, 2023 | −$0.47 | −$0.60 | −28.56% | $15.9M | SEC |
| Q3 2022 | Nov 10, 2022 | −$0.40 | −$0.23 | +42.02% | $16.1M | — |
| Q2 2022 | Aug 9, 2022 | −$0.26 | −$0.15 | +41.57% | $18.3M | — |
| Q1 2022 | May 10, 2022 | −$0.31 | −$0.08 | +74.19% | $23.3M | — |
| Q4 2021 | Mar 24, 2022 | −$0.41 | −$1.64 | −296.81% | $17.5M | SEC |
| Q3 2021 | Dec 10, 2021 | −$0.87 | −$1.16 | −33.33% | $19.6M | — |
Quarterly revenue
Frequently asked questions
When did Journey Medical (DERM) last report earnings?
Journey Medical last reported on Aug 12, 2026, covering fiscal Q2 2026.
Did DERM beat earnings estimates?
Yes. Journey Medical reported EPS of −$0.01 for Q2 2026 against a −$0.02 estimate — a 55.56% beat.
How much revenue did DERM report last quarter?
Journey Medical reported $18.5M in revenue for Q2 2026, against a consensus estimate of $18.4M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.